Ontology highlight
ABSTRACT:
INSTRUMENT(S): TripleTOF 6600
ORGANISM(S): Mus Musculus (mouse)
TISSUE(S): Liver
DISEASE(S): Non-alcoholic Fatty Liver Disease
SUBMITTER: Maciej Suski
LAB HEAD: Rafal Olszanecki
PROVIDER: PXD028535 | Pride | 2024-08-09
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
20210909_082144_Ania_apoE_liver_cytosol_TUG.sne | Other | |||
20210909_094538_Ania_apoE_liver_mitochondria_TUG.sne | Other | |||
C382T.wiff | Wiff | |||
C382T.wiff.scan | Wiff | |||
C384K.wiff | Wiff |
Items per page: 5 1 - 5 of 64 |
Kiepura Anna A Suski Maciej M Stachyra Kamila K Kuś Katarzyna K Czepiel Klaudia K Wiśniewska Anna A Ulatowska-Białas Magdalena M Olszanecki Rafał R
Cardiovascular drugs and therapy 20230127 4
<h4>Background</h4>Nonalcoholic fatty liver disease (NAFLD) constitutes an independent risk factor for the development of coronary heart disease. Low-grade inflammation has been shown to play an important role in the development of atherosclerosis and NAFLD. Free fatty acid receptor 4 (FFAR4/GPR120), which is involved in damping inflammatory reactions, may represent a promising target for the treatment of inflammatory diseases. Our objective was to evaluate the effect of TUG-891, the synthetic a ...[more]